Do pathological fractures influence survival and local recurrence rate in bony sarcomas?

被引:82
作者
Bramer, J. A. M.
Abudu, A. A.
Grimer, R. J.
Carter, S. R.
Tillman, R. M.
机构
[1] Acad Med Ctr, Dept Orthopaed Surg, NL-1100 DD Amsterdam, Netherlands
[2] Royal Orthopaed Hosp, Birmingham B31 2AP, W Midlands, England
关键词
osteosarcoma; Ewing's sarcoma; chondrosarcoma; pathological fracture; survival; local recurrence; prognosis;
D O I
10.1016/j.ejca.2007.07.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The influence of pathological fracture on surgical management, local recurrence and survival was established in patients with high grade, localised, extremity osteosarcoma (n = 484), chondrosarcoma (n = 130) and Ewing's sarcoma (n = 156). Limb salvage was possible in 79% of patients with a fracture compared to 84% of patients without a fracture (p = 0.17). No difference in local recurrence was found between fracture and control groups. In univariate analysis, survival in the fracture group was lower than in the control group for osteosarcoma (34% versus 58%, p < 0.01) and chondrosarcoma (35% versus 63%, p = 0.04), but not for Ewing's sarcoma (75% versus 64%, p = 0.80). In multivariate analysis, fracture remained a significant predictor of survival for osteosarcoma, but not for chondrosarcoma, where dedifferentiated subtype appeared to be decisive. Pathological fracture independently predicts worse survival in osteosarcoma, but not chondrosarcoma and Ewing's sarcoma. Limb saving surgery seems safe, if adequate resection margins are achieved. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1944 / 1951
页数:8
相关论文
共 35 条
[1]   The surgical treatment and outcome of pathological fractures in localised osteosarcoma [J].
Abudu, A ;
Sferopoulos, NK ;
Tillman, RM ;
Carter, SR ;
Grimer, RJ .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1996, 78B (05) :694-698
[2]   Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation - Local and systemic control by amputation or limb salvage after preoperative chemotherapy [J].
Bacci, G ;
Ferrari, S ;
Longhi, A ;
Donati, D ;
Manfrini, M ;
Giacomini, S ;
Briccoli, A ;
Forni, C ;
Galletti, S .
ACTA ORTHOPAEDICA SCANDINAVICA, 2003, 74 (04) :449-454
[3]   Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy - 15-year experience in 789 patients treated at a single institution [J].
Bacci, G ;
Longhi, A ;
Versari, M ;
Mercuri, M ;
Briccoli, A ;
Picci, P .
CANCER, 2006, 106 (05) :1154-1161
[4]   Pathologic fracture in osteosarcoma [J].
Bacci, G .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2003, 85A (09) :1848-1848
[5]  
Bergh P, 2001, CANCER-AM CANCER SOC, V91, P1201, DOI 10.1002/1097-0142(20010401)91:7<1201::AID-CNCR1120>3.0.CO
[6]  
2-W
[7]   Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European osteosarcoma intergroup study [J].
Bramwell, VHC ;
Steward, WP ;
Nooij, M ;
Whelan, J ;
Craft, AW ;
Grimer, RJ ;
Taminau, AHM ;
Cannon, SR ;
Malcolm, AJ ;
Hogendoorn, PCW ;
Uscinska, B ;
Kirkpatrick, AL ;
Machin, D ;
Van Glabbeke, MM .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3260-3269
[8]   Prognostic factors in Ewing's tumor of bone:: Analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study group [J].
Cotterill, SJ ;
Ahrens, S ;
Paulussen, M ;
Jürgens, HF ;
Voûte, PA ;
Gadner, H ;
Craft, AW .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) :3108-3114
[9]   Ifosfamide-containing chemotherapy in Ewing's sarcoma: The second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's tumor study [J].
Craft, A ;
Cotterill, S ;
Malcolm, A ;
Spooner, D ;
Grimer, R ;
Souhami, R ;
Imeson, J ;
Lewis, I .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) :3628-3633
[10]  
DAHLIN DC, 1978, CANCER TREAT REP, V62, P189